David Keiser is listed as a director on 7 SEC Form D filings by 2 issuers between Oct 2012 and Dec 2020: SELEXYS PHARMACEUTICALS CORP (Oklahoma City, OK — biotechnology — 2012–2015; $43.2M reported sold to 57 investors) and Tetherex Pharmaceuticals Corp (Oklahoma City, OK — biotechnology — 2015–2020; $43M reported sold to 240 investors).
What this means 2 separate companies raised money with this person listed as director, over about 8 years. Across those companies the filings report $86.2M sold in total.
1 of the issuers belongs to the sponsor group Tetherex (2 issuers, $26K reported sold, 2015–2025).
What this means A sponsor group is one team that sets up a new company for each deal. Tetherex has 2 companies on file and $26K reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 11 bankruptcy cases matching the name listed in Key records below.
What this means 11 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 7 public filings for David Keiser and found 7 differences, 1 worth asking the sponsor about: Bankruptcy case: DAVID A. KEISER and RHONDA L. KEISER; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.